The fallacy of reduction

Pediatric Diabetes

Volumn 13, Issue 4, 2012, Pages 340-343

  Rewers, Marian ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Accelerator; Autoimmunity; Children; Epidemic; Insulin resistance; Obesity; Prospective studies; Type 1 diabetes; Weight gain

Indexed keywords

GLUCOSE; INSULIN; AUTOANTIBODY;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; WEIGHT GAIN; CHILD; IMMUNOLOGY; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY;

AUTOANTIBODIES; AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; WEIGHT GAIN;

EID: 84861695885     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00832.x     Document Type: Article

References (18)

1. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001: 44: 914-922.
2. Wilkin TJ. The convergence of type 1 and type 2 diabetes in childhood. Pediatr Diabetes 2011.
3. Hyöty H, Taylor KW. The role of viruses in human diabetes. Diabetol 2002: 45: 1353-1361.
4. Christen U, von Herrath MG. Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference? Cell Mol Immunol 2011: 8: 193-198.
5. Rubio-Cabezas O, Minton JA, Caswell R et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care 2009: 32: 111-116.
6. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004: 47: 1661-1667.
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985: 28: 412-419.
8. Bingley PJ, Colman P, Eisenbarth GS et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992: 15: 1313-1316.
9. Mrena S, Virtanen SM, Laippala P et al. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 2006: 29: 662-667.
10. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007: 30: 2314-2320.
11. Bingley PJ, Mahon JL, Gale EA. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 2008: 31: 146-150.
12. Lamb MM, Yin X, Zerbe GO et al. Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia 2009: 52: 2064-2071.
13. Winkler C, Marienfeld S, Zwilling M, Bonifacio E, Ziegler AG. Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes? Diabetologia 2009: 52: 2072-2078.
14. Couper JJ, Beresford S, Hirte C et al. Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 2009: 32: 94-99.
15. Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000: 23: 1755-1760.
16. Bruining GJ. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 2000: 356: 655-656.
17. Baum JD, Ounsted M, Smith MA. Weight gain in infancy and subsequent development of diabetes mellitus in childhood. Lancet 1975: 2: 866 (Letter).
18. Wilkin TJ. Autoimmune diabetes and the germ theory of disease. Diabetologia 1992: 35: 187-189.